Access to the abortion pill mifepristone remains unchanged as the U.S. Supreme Court rejected a roll back attempt, depending on state laws for availability.
Legal battle over mifepristone focused on standing to sue the FDA, with experts suggesting potential future legal challenges despite current decision.
Status quo preserved by the Supreme Court ruling, maintaining access to mifepristone, but not eliminating the possibility of future legal disputes regarding the drug.
Collection
[
|
...
]